GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vistin Pharma ASA (OSL:VISTN) » Definitions » Book Value per Share

Vistin Pharma ASA (OSL:VISTN) Book Value per Share : kr7.01 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vistin Pharma ASA Book Value per Share?

Vistin Pharma ASA's book value per share for the quarter that ended in Sep. 2024 was kr7.01.

During the past 12 months, Vistin Pharma ASA's average Book Value Per Share Growth Rate was 3.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -4.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Vistin Pharma ASA was 5.80% per year. The lowest was -12.90% per year. And the median was -4.15% per year.

Vistin Pharma ASA's current price is kr24.00. Its book value per share for the quarter that ended in Sep. 2024 was kr7.01. Hence, today's PB Ratio of Vistin Pharma ASA is 3.43.

During the past 11 years, the highest P/B Ratio of Vistin Pharma ASA was 4.34. The lowest was 0.59. And the median was 2.20.


Vistin Pharma ASA Book Value per Share Historical Data

The historical data trend for Vistin Pharma ASA's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vistin Pharma ASA Book Value per Share Chart

Vistin Pharma ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.32 6.14 6.22 6.17 7.28

Vistin Pharma ASA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.79 7.28 6.70 6.63 7.01

Competitive Comparison of Vistin Pharma ASA's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vistin Pharma ASA's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's PB Ratio distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's PB Ratio falls into.



Vistin Pharma ASA Book Value per Share Calculation

Vistin Pharma ASA's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(322.8-0.0)/44.3
=7.28

Vistin Pharma ASA's Book Value Per Share for the quarter that ended in Sep. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(310.7-0.0)/44.3
=7.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Vistin Pharma ASA  (OSL:VISTN) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Vistin Pharma ASA Book Value per Share Related Terms

Thank you for viewing the detailed overview of Vistin Pharma ASA's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vistin Pharma ASA Business Description

Traded in Other Exchanges
Address
Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.

Vistin Pharma ASA Headlines

No Headlines